163 related articles for article (PubMed ID: 1356363)
1. Ideal and reality of neuroleptic relapse prevention.
Kissling W
Br J Psychiatry Suppl; 1992 Oct; (18):133-9. PubMed ID: 1356363
[No Abstract] [Full Text] [Related]
2. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to prescribe an APAP?].
Dassa D; Lacambre M; Vacheron MN
Encephale; 2009 Jan; Suppl 3():S109-13. PubMed ID: 19268179
[No Abstract] [Full Text] [Related]
3. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
Kopala LC; Fredrikson D; Good KP; Honer WG
Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
[No Abstract] [Full Text] [Related]
4. Neuroleptic prescription for Chinese schizophrenics in Hong Kong.
Chiu H; Lee S; Leung CM; Wing YK
Aust N Z J Psychiatry; 1992 Jun; 26(2):262-4. PubMed ID: 1353673
[TBL] [Abstract][Full Text] [Related]
5. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
Buis C; Gourion D; Vaiva G
Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185
[No Abstract] [Full Text] [Related]
6. Treating prodromal episodes to prevent relapse in schizophrenia.
Herz MI; Glazer W; Mirza M; Mostert M; Hafez H
Br J Psychiatry Suppl; 1989 Jul; (5):123-7. PubMed ID: 2574984
[No Abstract] [Full Text] [Related]
7. [Noncompliance--a typical problem in psychiatric patients. Individual, social and illness-specific factors].
Hartung HD
Fortschr Med; 1998 Jan; 116(3):28-30. PubMed ID: 9522542
[No Abstract] [Full Text] [Related]
8. [Detection of early warning signs in schizophrenic patients. Possible applications in prevention of recurrence].
Wiedemann G; Hahlweg K; Hank G; Feinstein E; Müller U; Dose M
Nervenarzt; 1994 Jul; 65(7):438-43. PubMed ID: 7800087
[TBL] [Abstract][Full Text] [Related]
9. Reducing the dose of depot neuroleptics in stable schizophrenia.
Dale R; Longdon M; Seeman MV
J Psychiatry Neurosci; 1994 Jul; 19(4):278-81. PubMed ID: 7918349
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
[TBL] [Abstract][Full Text] [Related]
11. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?].
Hornung WP; Buchkremer G; Redbrake M; Klingberg S
Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic medication: clinical guidelines for maintenance therapy.
Johnson DA
J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
[TBL] [Abstract][Full Text] [Related]
13. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
Faraone SV; Brown WA; Laughren TP
J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
[TBL] [Abstract][Full Text] [Related]
14. Management of treatment refractory schizophrenia.
Morrison DP
Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
[No Abstract] [Full Text] [Related]
15. Relapse prevention and recovery in the treatment of schizophrenia.
Schooler NR
J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
[TBL] [Abstract][Full Text] [Related]
16. ICI 204,636: a new atypical antipsychotic drug.
Hirsch SR; Link CG; Goldstein JM; Arvanitis LA
Br J Psychiatry Suppl; 1996 May; (29):45-56. PubMed ID: 8733823
[No Abstract] [Full Text] [Related]
17. [Prolactinemia and predictability of therapeutic response of schizophrenic patients in acute decompensation].
Vanelle JM; Amorim P; Piketti ML; Bourdel MC; Poirier-Littré MF
Encephale; 1996 Oct; 22 Spec No 3():82-4. PubMed ID: 8954284
[No Abstract] [Full Text] [Related]
18. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
Barnes TR; Liddle PF; Curson DA; Patel M
Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
[No Abstract] [Full Text] [Related]
19. [Arguments for early treatment of refractory schizophrenia].
Lombertie ER; Salome N; Villegier P; Laghrissi-Thode F; Nassif F
Encephale; 1995 Jun; 21 Spec No 3():29-33. PubMed ID: 7628338
[TBL] [Abstract][Full Text] [Related]
20. Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse?
Gaebel W; Frick U; Köpcke W; Linden M; Müller P; Müller-Spahn F; Pietzcker A; Tegeler J
Br J Psychiatry Suppl; 1993 Sep; (21):8-12. PubMed ID: 8105814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
